When to cut one the umbilical cord has become the center of an international debate for decades.
The Pentagon on Friday identified five more potentially live Anthrax samples that were sent to labs, and a review has been ordered.
Researchers unravel the biggest of all dairy mysteries.
California's probably not experiencing a tsunami anytime soon
CHICAGO (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.